{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:30Z","timestamp":1792839750657,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.amjmed.2015.02.017","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T02:03:39Z","timestamp":1428285819000},"page":"950-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"title":["Cryoglobulinemia Vasculitis"],"prefix":"10.1016","volume":"128","author":[{"given":"Patrice","family":"Cacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cloe","family":"Comarmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Savey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2015.02.017_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/BOR.0b013e32835b15f7","article-title":"Cryoglobulinemia vasculitis: an update","volume":"25","author":"Terrier","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.amjmed.2015.02.017_bib2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2015.02.017_bib3","series-title":"EULAR Compendium on Rheumatic Diseases","first-page":"616","article-title":"Cryoglobulinemia and systemic manifestations of hepatitis C","author":"Ferri","year":"2009"},{"issue":"5","key":"10.1016\/j.amjmed.2015.02.017_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2015.02.017_bib5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/clinchem\/38.6.798","article-title":"Characterization of cryoglobulins by immunoblotting","volume":"38","author":"Musset","year":"1992","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.amjmed.2015.02.017_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","article-title":"Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center","volume":"80","author":"Trejo","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.amjmed.2015.02.017_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjmed.2015.02.017_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjmed.2015.02.017_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2015.02.017_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/03009740903313639","article-title":"Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus","volume":"39","author":"Della Rossa","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.amjmed.2015.02.017_bib11","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","article-title":"Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis","volume":"63","author":"Terrier","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2015.02.017_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"25","key":"10.1016\/j.amjmed.2015.02.017_bib13","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-12-396028","article-title":"Management of non infectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey","volume":"119","author":"Terrier","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.amjmed.2015.02.017_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/annrheumdis-2012-201405","article-title":"Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey","volume":"72","author":"Terrier","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"10.1016\/j.amjmed.2015.02.017_bib15","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","article-title":"Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia","volume":"166","author":"Saadoun","year":"2006","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.amjmed.2015.02.017_bib16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/acr.20318","article-title":"Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.amjmed.2015.02.017_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/annrheumdis-2013-203883","article-title":"Hepatitis C virus-induced vasculitis: therapeutic options","volume":"73","author":"Cacoub","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.amjmed.2015.02.017_bib18","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow up study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.amjmed.2015.02.017_bib19","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/art.24703","article-title":"Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients","volume":"60","author":"Terrier","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.amjmed.2015.02.017_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.amjmed.2015.02.017_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"Peg-IFN\u03b1Ribavirin\/Protease inhibitor combination in severe hepatitis C virus associated mixed cryoglobulinemia vasculitis","volume":"62","author":"Saadoun","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.amjmed.2015.02.017_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.dld.2014.05.017","article-title":"Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study","volume":"46","author":"Gragnani","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2015.02.017_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","author":"European Association for Study of Liver","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.amjmed.2015.02.017_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?","volume":"67","author":"Cacoub","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2015.02.017_bib25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A\u00a0randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.amjmed.2015.02.017_bib26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A\u00a0randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.amjmed.2015.02.017_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.amjmed.2015.02.017_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.amjmed.2015.02.017_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/acr.21856","article-title":"Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma","volume":"65","author":"Saadoun","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.amjmed.2015.02.017_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934315002521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934315002521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:06:17Z","timestamp":1757581577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934315002521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0002934315002521"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2015.02.017","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryoglobulinemia Vasculitis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2015.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}